DrugPatentWatch Database Preview
PRAXBIND Drug Profile
» See Plans and Pricing
Summary for Tradename: PRAXBIND
| Patents: | 3 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for PRAXBIND
| Ingredient-type | Antibodies, Monoclonal, Humanized |
Patent Text Search: US Patents for PRAXBIND
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | PRAXBIND | idarucizumab | INJECTABLE;INJECTION | 761025 | 001 | 2015-10-16 | Start Trial | Haemonetics Corporation (Braintree, MA) | 2034-07-31 | RX | Orphan | search |
| Boehringer Ingelheim | PRAXBIND | idarucizumab | INJECTABLE;INJECTION | 761025 | 001 | 2015-10-16 | Start Trial | The Regents of the University of California (Oakland, CA) | 2035-02-24 | RX | Orphan | search |
| Boehringer Ingelheim | PRAXBIND | idarucizumab | INJECTABLE;INJECTION | 761025 | 001 | 2015-10-16 | Start Trial | LA JOLLA BIOLOGICS, INC. (San Diego, CA) | 2036-04-26 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for PRAXBIND
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016138034 | Start Trial |
| Canada | 2973890 | Start Trial |
| Japan | 2018506293 | Start Trial |
| Hong Kong | 1223151 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
